Plosaracetam

DB21594InvestigationalSmall molecule

Plosaracetam is a small molecule drug. The usage of the INN stem '-racetam' in the name indicates that Plosaracetam is a piracetam type amide type nootrope agent. Plosaracetam is under... Plosaracetam is under investigation in clinical trial NCT05199142 (A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SDI-118 in Elderly Male and Female Study Participants With Cognitive Decline).

Mechanism: Pharmacologically active on Synaptic vesicle glycoprotein 2A
Curator reviewed
Formula / weight: C₁₃H₁₀ClF₃N₄O · 330.7 g/mol (avg)
Code names: SDI-118

Resolves to

Compound

UNIIW3LYF2KQ6FCAS1651179-19-9ChEMBLCHEMBL5314929ChEBI759621PubChem90467376

Structure

InChIKeyGPGBFZCJDZALPN-QMMMGPOBSA-NSMILESFC1=CC(=CC(F)=C1F)[C@@H]1CN(CN2N=CN=C2Cl)C(=O)C1

Targets

Q7L0J3SV2A

What you can answer from here — as of October 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Plosaracetam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account